BridgeBio Pharma BBIO
NASDAQ BBIO
$79.54 +0.87 (+1.11%)
At close: Nov 11, 2026 · 4:00 PM EST

BridgeBio Pharma (BBIO) Share-based Compensation (2018 - 2026)

Updated

BridgeBio Pharma's Share-based Compensation was $39.86 million in Q3 2026, up 13.0% from $35.26 million a year earlier but down 9.6% from the prior quarter.

Analysis

BridgeBio Pharma (BBIO) Share-based Compensation (2018 - 2026) Analysis & Trends

On a trailing twelve-month basis, BridgeBio Pharma's Share-based Compensation was $151.81 million through Sep 30, 2026, up 18.0% year-over-year; for FY2025, it came in at $133.02 million, up 38.9% from FY2024.

  • Share-based Compensation shows a five-year compound annual growth rate of 17.9% (FY2020 to FY2025).
  • In earlier years, Share-based Compensation was $95.8 million in FY2024 (-11.9%), $108.71 million in FY2023 (+15.9%), $93.83 million in FY2022 (-11.1%) and $105.57 million in FY2021 (+80.6%).
  • Quarterly Share-based Compensation has moved between $18.66 million (Q3 2022) and $44.07 million (Q2 2026) over five years.
  • Compared with a year earlier, Share-based Compensation has increased for six straight quarters, with growth averaging 20.7% over the last eight quarters.
  • The best year-over-year quarter for Share-based Compensation over five years was Q4 2021 (growth of 85.4%); the worst was Q1 2022 (a decline of 30.4%).
  • Per Business Quant data, BBIO's Share-based Compensation in the three quarters before Q3 2026 was $44.07 million (Q2 2026), $33.24 million (Q1 2026) and $34.64 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 200.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 357.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 160.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 369.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 128.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 234.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 362.00 Mn
10 BridgeBio Pharma 15.42 Bn 11.64 Bn 332.72 Mn 39.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 39.86 Mn
Jun 30, 2026 44.07 Mn
Mar 31, 2026 33.24 Mn
Dec 31, 2025 34.64 Mn
Sep 30, 2025 35.26 Mn
Jun 30, 2025 37.34 Mn
Mar 31, 2025 25.88 Mn
Dec 31, 2024 30.13 Mn
Sep 30, 2024 27.13 Mn
Jun 30, 2024 21.45 Mn
Mar 31, 2024 28.85 Mn
Dec 31, 2023 30.83 Mn
Sep 30, 2023 27.23 Mn
Jun 30, 2023 27.18 Mn
Mar 31, 2023 23.48 Mn
Dec 31, 2022 22.58 Mn
Sep 30, 2022 18.66 Mn
Jun 30, 2022 28.31 Mn
Mar 31, 2022 24.28 Mn
Dec 31, 2021 22.51 Mn
API Access

BridgeBio Pharma Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=BBIO&period=max&api_key=YOUR_API_KEY